New York State Teachers Retirement System Has $77.94 Million Stake in HCA Healthcare, Inc. (NYSE:HCA)

New York State Teachers Retirement System trimmed its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 7.8% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 191,761 shares of the company’s stock after selling 16,202 shares during the period. New York State Teachers Retirement System owned about 0.07% of HCA Healthcare worth $77,937,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also modified their holdings of the company. Vanguard Group Inc. lifted its holdings in HCA Healthcare by 0.4% during the 1st quarter. Vanguard Group Inc. now owns 16,989,683 shares of the company’s stock worth $5,666,569,000 after purchasing an additional 60,304 shares during the last quarter. Capital World Investors boosted its holdings in shares of HCA Healthcare by 57.5% in the 1st quarter. Capital World Investors now owns 2,792,377 shares of the company’s stock valued at $931,342,000 after purchasing an additional 1,019,750 shares in the last quarter. Darsana Capital Partners LP increased its position in HCA Healthcare by 53.3% during the 2nd quarter. Darsana Capital Partners LP now owns 1,150,000 shares of the company’s stock worth $369,472,000 after purchasing an additional 400,000 shares in the last quarter. TD Asset Management Inc increased its holdings in shares of HCA Healthcare by 2.7% during the second quarter. TD Asset Management Inc now owns 741,130 shares of the company’s stock worth $238,110,000 after buying an additional 19,812 shares in the last quarter. Finally, Epoch Investment Partners Inc. raised its position in HCA Healthcare by 16.4% in the second quarter. Epoch Investment Partners Inc. now owns 631,854 shares of the company’s stock valued at $203,002,000 after purchasing an additional 88,948 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of research firms have issued reports on HCA. Leerink Partners increased their price target on HCA Healthcare from $367.00 to $396.00 and gave the stock an “outperform” rating in a report on Wednesday, July 24th. Royal Bank of Canada upped their target price on shares of HCA Healthcare from $378.00 to $405.00 and gave the stock an “outperform” rating in a research note on Friday, August 23rd. Truist Financial boosted their price target on shares of HCA Healthcare from $390.00 to $430.00 and gave the stock a “buy” rating in a report on Monday, August 19th. Barclays boosted their price target on shares of HCA Healthcare from $376.00 to $396.00 and gave the stock an “overweight” rating in a report on Wednesday, July 24th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $392.00 price objective on shares of HCA Healthcare in a report on Tuesday, October 1st. Five equities research analysts have rated the stock with a hold rating, thirteen have given a buy rating and three have given a strong buy rating to the company. According to data from MarketBeat.com, HCA Healthcare presently has a consensus rating of “Moderate Buy” and an average price target of $379.11.

HCA Healthcare Stock Performance

Shares of HCA stock traded up $1.70 during trading hours on Wednesday, reaching $362.37. 119,935 shares of the company traded hands, compared to its average volume of 1,158,767. The company has a debt-to-equity ratio of 27.11, a current ratio of 1.06 and a quick ratio of 0.94. HCA Healthcare, Inc. has a 12-month low of $223.73 and a 12-month high of $417.14. The firm has a 50-day moving average price of $394.42 and a 200 day moving average price of $353.21. The company has a market cap of $94.91 billion, a P/E ratio of 17.98, a P/E/G ratio of 1.52 and a beta of 1.67.

HCA Healthcare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Friday, December 13th will be paid a $0.66 dividend. The ex-dividend date is Friday, December 13th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.73%. HCA Healthcare’s payout ratio is currently 13.16%.

Insider Buying and Selling

In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of the business’s stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the sale, the executive vice president now owns 29,678 shares in the company, valued at approximately $11,438,494.76. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.60% of the stock is currently owned by company insiders.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.